Real-world effectiveness and safety of zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.
Author / Organization: Martin-Moro F, Muntañola A, Gutiérrez X, Vázquez MS, Morais L, Amarika I, Diez-Feijóo R, Bastos-Oreiro M, Cruz B, Marco-Ayala J, Ramos S, Jiménez-Ubieto A, Galindo-Navarro P, Correa JG, Lavilla E, García-Herce C, Moreno M, Domingo-Doménech E, Domínguez N, Alonso A, Otero MJ, Comai A, Bengochea ML, Villegas Da Ros C, Gutiérrez NC, Lluch R, Fernández-Luis S, Soler JA, Cannata-Ortiz MJ, Medina Á, Martín-Consuegra S, Aceituno M, Villafuerte P, de Miguel D, Arguiñano JM, López J, Villalón L, Gulino H, López-Guillermo A, Salar A, Grupo Español de Linfomas/Trasplante de Médula ósea (GELTAMO)
| File Format | PDF (Portable Document Format) |
|---|---|
| Source Host |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.